Literature DB >> 17216208

The functional Pro129Thr variant of the FAAH gene is not associated with various fat accumulation phenotypes in a population-based cohort of 5,801 whites.

Dorit P Jensen1, Camilla H Andreasen, Mette K Andersen, Lars Hansen, Hans Eiberg, Knut Borch-Johnsen, Torben Jørgensen, Torben Hansen, Oluf Pedersen.   

Abstract

Food intake and weight gain are influenced by endocannabinoids whose actions are regulated by the fatty acid amide hydrolase (FAAH) enzyme. The homozygous Thr/Thr genotype of the functional Pro129Thr variant (rs324420) in the gene encoding FAAH was recently reported to associate with overweight and obesity in white and black populations. We investigated the Pro129Thr variant in relation to overweight and obesity in a relatively large population-based study sample of Danish whites (n=5,801). In case-control studies of obesity, a borderline association with the major Pro allele was identified; however, after correction for multiple testing, no association was found. Furthermore, a possible association between the major Pro allele and obesity was not supported by studies of obesity-related quantitative traits. In conclusion, in a large study sample, we were unable to find robust evidence of an association of the Pro129Thr FAAH variant with overweight, obesity, and any related quantitative traits among the examined whites.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17216208     DOI: 10.1007/s00109-006-0139-0

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   5.606


  18 in total

Review 1.  Cannabinoids and the gastrointestinal tract.

Authors:  R G Pertwee
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  A randomized non-pharmacological intervention study for prevention of ischaemic heart disease: baseline results Inter99.

Authors:  Torben Jørgensen; Knut Borch-Johnsen; Troels F Thomsen; Hans Ibsen; Charlotte Glümer; Charlotta Pisinger
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2003-10

3.  Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides.

Authors:  B F Cravatt; D K Giang; S P Mayfield; D L Boger; R A Lerner; N B Gilula
Journal:  Nature       Date:  1996-11-07       Impact factor: 49.962

Review 4.  The emerging role of the endocannabinoid system in endocrine regulation and energy balance.

Authors:  Uberto Pagotto; Giovanni Marsicano; Daniela Cota; Beat Lutz; Renato Pasquali
Journal:  Endocr Rev       Date:  2005-11-23       Impact factor: 19.871

5.  Activation of the peripheral endocannabinoid system in human obesity.

Authors:  Stefan Engeli; Jana Böhnke; Mareike Feldpausch; Kerstin Gorzelniak; Jürgen Janke; Sándor Bátkai; Pál Pacher; Judy Harvey-White; Friedrich C Luft; Arya M Sharma; Jens Jordan
Journal:  Diabetes       Date:  2005-10       Impact factor: 9.461

6.  Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase.

Authors:  B F Cravatt; K Demarest; M P Patricelli; M H Bracey; D K Giang; B R Martin; A H Lichtman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-24       Impact factor: 11.205

Review 7.  Endogenous cannabinoid system as a modulator of food intake.

Authors:  D Cota; G Marsicano; B Lutz; V Vicennati; G K Stalla; R Pasquali; U Pagotto
Journal:  Int J Obes Relat Metab Disord       Date:  2003-03

8.  Overweight and obesity associated with a missense polymorphism in fatty acid amide hydrolase (FAAH).

Authors:  J C Sipe; J Waalen; A Gerber; E Beutler
Journal:  Int J Obes (Lond)       Date:  2005-07       Impact factor: 5.095

9.  Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats.

Authors:  N Jamshidi; D A Taylor
Journal:  Br J Pharmacol       Date:  2001-11       Impact factor: 8.739

10.  Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use.

Authors:  Kyle P Chiang; Alexandra L Gerber; Jack C Sipe; Benjamin F Cravatt
Journal:  Hum Mol Genet       Date:  2004-07-14       Impact factor: 6.150

View more
  17 in total

Review 1.  Recent progress in the genetics of common obesity.

Authors:  Ruth J F Loos
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

Review 2.  Enzymatic pathways that regulate endocannabinoid signaling in the nervous system.

Authors:  Kay Ahn; Michele K McKinney; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2008-04-23       Impact factor: 60.622

3.  Racial and sex differences in the polymorphisms of the endocannabinoid receptor genes in obesity.

Authors:  Tina K Thethi; Aster Sigel; Shanker Japa; Bonnie Katalenich; Shuqian Liu; Tuyen Nguyen; Joshua Larrazolo; Stephanie Syu; Esther Carefoot; Roberta McDuffie; Vivian Fonseca
Journal:  J Diabetes Complications       Date:  2020-07-17       Impact factor: 2.852

Review 4.  The endocannabinoid system in obesity and type 2 diabetes.

Authors:  V Di Marzo
Journal:  Diabetologia       Date:  2008-06-18       Impact factor: 10.122

5.  Obesity-related dyslipidemia associated with FAAH, independent of insulin response, in multigenerational families of Northern European descent.

Authors:  Yi Zhang; Gabriele E Sonnenberg; Tesfaye Mersha Baye; Jack Littrell; Jennifer Gunnell; Ann DeLaForest; Erin MacKinney; Cecilia J Hillard; Ahmed H Kissebah; Michael Olivier; Russell A Wilke
Journal:  Pharmacogenomics       Date:  2009-12       Impact factor: 2.533

6.  A covering method for detecting genetic associations between rare variants and common phenotypes.

Authors:  Gaurav Bhatia; Vikas Bansal; Olivier Harismendy; Nicholas J Schork; Eric J Topol; Kelly Frazer; Vineet Bafna
Journal:  PLoS Comput Biol       Date:  2010-10-14       Impact factor: 4.475

7.  Distinct and replicable genetic risk factors for acute respiratory distress syndrome of pulmonary or extrapulmonary origin.

Authors:  Paula Tejera; Nuala J Meyer; Feng Chen; Rui Feng; Yang Zhao; D Shane O'Mahony; Lin Li; Chau-Chyun Sheu; Rihong Zhai; Zhaoxi Wang; Li Su; Ed Bajwa; Amy M Ahasic; Peter F Clardy; Michelle N Gong; Angela J Frank; Paul N Lanken; B Taylor Thompson; Jason D Christie; Mark M Wurfel; Grant E O'Keefe; David C Christiani
Journal:  J Med Genet       Date:  2012-10-09       Impact factor: 6.318

Review 8.  Cannabinoids for clinicians: the rise and fall of the cannabinoid antagonists.

Authors:  Helen Butler; Márta Korbonits
Journal:  Eur J Endocrinol       Date:  2009-09-03       Impact factor: 6.664

9.  Mutation screen and association studies for the fatty acid amide hydrolase (FAAH) gene and early onset and adult obesity.

Authors:  Timo D Müller; Günter Brönner; Melanie Wandolski; Jophia Carrie; Trang T Nguyen; Brandon H Greene; André Scherag; Harald Grallert; Carla Ig Vogel; Susann Scherag; Winfried Rief; Hans-Erich Wichmann; Thomas Illig; Helmut Schäfer; Johannes Hebebrand; Anke Hinney
Journal:  BMC Med Genet       Date:  2010-01-01       Impact factor: 2.103

10.  Biomarkers of endocannabinoid system activation in severe obesity.

Authors:  Jack C Sipe; T Michael Scott; Sarah Murray; Olivier Harismendy; Gabriel M Simon; Benjamin F Cravatt; Jill Waalen
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.